E Ruud Selected Research

Neuroblastoma

1/2021

Central nervous system relapse in high-risk stage 4 neuroblastoma: The HR-NBL1/SIOPEN trial experience.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

E Ruud Research Topics

Disease

3	Neoplasms (Cancer) 01/2006 - 05/2001
1	Neuroblastoma 01/2021
1	Congenital Heart Defects (Congenital Heart Defect) 01/2006
1	Lymphoma (Lymphomas) 01/2006
1	Nephrotic Syndrome (Syndrome, Nephrotic) 08/2003
1	Pulmonary Embolism 08/2003
1	Thromboembolism 08/2003
1	Thrombosis (Thrombus) 08/2003
1	Infections 05/2001
1	Medulloblastoma 05/2001

Drug/Important Bio-Agent (IBA)

1	Lipoprotein(a)IBA 01/2006
1	HomocysteineIBA 01/2006
1	Tissue Plasminogen Activator (Alteplase)FDA Link 08/2003
1	AntibodiesIBA 01/2002
1	AnticoagulantsIBA 01/2002
1	Biomarkers (Surrogate Marker)IBA 01/2002
1	Alkylating AgentsIBA 05/2001

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 01/2021 - 05/2001
1	Immunotherapy 01/2021
1	Catheters 08/2003
1	Therapeutics 01/2002